Unicycive Therapeutics, Inc.
NASDAQ:UNCY
0.4347 (USD) • At close October 21, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet
| 0 | 0 | -0.271 | 0 | 0 | 0.675 | 0 | 0.951 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Kosten van de omzet
| 0 | 0.284 | 0.082 | 0.079 | 0.078 | 0.045 | 0.002 | 0.001 | 0.002 | 0.002 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Brutowinst
| 0 | -0.284 | -0.353 | -0.079 | -0.078 | 0.63 | -0.002 | 0.95 | -0.002 | -0.002 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Brutowinstmarge
| 0 | 0 | 1.303 | 0 | 0 | 0.933 | 0 | 0.999 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Onderzoek- en ontwikkelingskosten
| 4.868 | 6.813 | 4.233 | 3.372 | 2.267 | 3.03 | 3.84 | 4.803 | 1.86 | 1.933 | 1.361 | 3.776 | 0.493 | 0.45 | 0.382 | 0.304 | 0.182 | 0.148 | 0.376 | 0.188 | 0.116 | 0.116 |
Algemene en administratieve kosten
| 2.533 | 2.391 | 2.08 | 2.566 | 2.055 | 1.847 | 1.485 | 1.702 | 1.776 | 1.604 | 1.391 | 0.939 | 0.286 | 0.281 | 0.335 | 0.322 | 0.154 | 0.194 | 0.325 | 0.293 | 0.275 | 0.275 |
Verkoop- en marketingkosten
| 0 | -0.284 | -0.082 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Verkoop-, algemene en administratieve kosten
| 2.533 | 2.107 | 1.998 | 2.566 | 2.055 | 1.847 | 1.485 | 1.702 | 1.776 | 1.604 | 1.391 | 0.939 | 0.286 | 0.281 | 0.335 | 0.322 | 0.154 | 0.194 | 0.325 | 0.293 | 0.275 | 0.275 |
Overige kosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bedrijfskosten
| 7.401 | 8.92 | 6.231 | 5.938 | 4.322 | 4.877 | 5.325 | 6.505 | 3.636 | 3.537 | 2.752 | 4.715 | 0.779 | 0.731 | 0.717 | 0.626 | 0.336 | 0.342 | 0.701 | 0.544 | 0.391 | 0.391 |
Bedrijfsresultaat
| -7.401 | -9.204 | -6.313 | -5.938 | -4.322 | -4.202 | -5.325 | -5.554 | -3.636 | -3.537 | -2.752 | -4.715 | -0.779 | -0.731 | -0.717 | -0.626 | -0.336 | -0.342 | -0.701 | -0.481 | -0.391 | -0.391 |
Bedrijfsresultaat ratio
| 0 | 0 | 23.295 | 0 | 0 | -6.225 | 0 | -5.84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Totaal overige inkomsten en kosten netto
| 17.256 | -11.759 | -1.485 | 1.533 | 0.282 | -10.373 | -0.003 | -0.003 | 0 | 0 | 0 | -0.431 | -0.321 | 0.019 | -0.163 | -0.076 | -0.002 | -0.002 | -0.001 | -0.083 | -0.059 | -0.059 |
Inkomen voor belasting
| 9.855 | -20.963 | -7.798 | -4.405 | -3.838 | -14.575 | -5.328 | -5.557 | -3.636 | -3.537 | -2.752 | -5.201 | -1.1 | -0.964 | -0.88 | -0.702 | -0.338 | -0.344 | -0.702 | -0.564 | -0.45 | -0.45 |
Inkomen voor belasting ratio
| 0 | 0 | 28.775 | 0 | 0 | -21.593 | 0 | -5.843 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Belastingkosten
| 5.925 | 0.241 | -10.53 | -0.079 | 0.032 | 10.577 | 0.003 | 0.003 | 0.038 | 0.037 | -0.412 | 0.431 | -0.779 | -0.019 | -0.717 | -0.626 | -0.336 | -0.342 | -0.001 | -0.083 | -0.059 | -0.059 |
Nettowinst
| 3.93 | -20.963 | -7.798 | -4.405 | -3.838 | -25.152 | -5.331 | -5.56 | -3.636 | -3.537 | -2.752 | -5.201 | -1.1 | -0.964 | -0.88 | -0.702 | -0.338 | -0.344 | -0.702 | -0.564 | -0.45 | -0.45 |
Nettowinstmarge
| 0 | 0 | 28.775 | 0 | 0 | -37.262 | 0 | -5.846 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
WPA (Winst Per Aandeel)
| 0.08 | -0.6 | -0.22 | -0.13 | -0.25 | -1.65 | -0.35 | -0.37 | -0.24 | -0.24 | -0.19 | -0.37 | -0.079 | -0.11 | -0.061 | -0.083 | -0.04 | -0.024 | -0.084 | -0.069 | -0.057 | -0.057 |
Verwaterde WPA
| 0.08 | -0.6 | -0.22 | -0.13 | -0.25 | -1.65 | -0.35 | -0.37 | -0.24 | -0.24 | -0.19 | -0.37 | -0.079 | -0.11 | -0.061 | -0.082 | -0.039 | -0.024 | -0.084 | -0.069 | -0.057 | -0.057 |
EBITDA
| -7.401 | -8.92 | -6.231 | -5.938 | -4.01 | -4.143 | -5.283 | -5.514 | -3.596 | -3.498 | -2.752 | -4.715 | -0.779 | -0.731 | -0.717 | -0.626 | -0.336 | -0.342 | -0.001 | -0.083 | -0.059 | -0.059 |
EBITDA ratio
| 0 | 0 | 22.993 | 0 | 0 | -6.138 | 0 | -5.798 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |